Inhibition of Endoplasmic Reticulum Stress is Involved in the Neuroprotective Effect of bFGF in the 6-OHDA-Induced Parkinson’s Disease Model-Reference-Cited by-同舟云学术

Inhibition of Endoplasmic Reticulum Stress is Involved in the Neuroprotective Effect of bFGF in the 6-OHDA-Induced Parkinson’s Disease Model

Published:2016 Issue:4 Volume:7 Page:336
ISSN:2152-5250
Container-title:Aging and disease
language:en
Short-container-title:Aging and disease

Author:

Cai Pingtao,Ye Jingjing,Zhu Jingjing,Liu Dan,Chen Daqing,Wei Xiaojie,Johnson Noah R.,Wang Zhouguang,Zhang Hongyu,Cao Guodong,Xiao Jian,Ye Junming,Lin Li

Publisher

Aging and Disease

Subject

Cell Biology,Clinical Neurology,Geriatrics and Gerontology,Pathology and Forensic Medicine

Link

http://www.aginganddisease.org/fileup/2152-5250/PDF/2152-5250-2016-4-336.pdf

Reference51 articles.

1. Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, et al. (2010). Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci, 11: 760-772

2. Schwarz J, Storch A (2010). Transplantation in Parkinson's disease: will mesenchymal stem cells help to reenter the clinical arena. Transl Res, 155: 55-56

3. Aminzadeh MA, Sato T, Vaziri ND (2012). Participation of endoplasmic reticulum stress in the pathogenesis of spontaneous glomerulosclerosis-Role of intra-renal angiotensin system. Transl Res, 160: 309-318

4. Li S, Yang L, Selzer ME, Hu Y (2013). Neuronal endoplasmic reticulum stress in axon injury and neurodegeneration. Ann Neurol, 74: 768-777

5. Cheng B, Gong H, Xiao H, Petersen RB, Zheng L, Huang K (2013). Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases. Biochim Biophys Acta, 1830: 4860-4871

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BFGF attenuates aortic valvular interstitial cell calcification by inhibiting endoplasmic reticulum stress-mediated apoptosis;Experimental Cell Research;2024-01

2. Structure and modification;Fibroblast Growth Factors;2024

3. Strategies targeting endoplasmic reticulum stress to improve Parkinson’s disease;Frontiers in Pharmacology;2023-11-10

4. Design, synthesis and evaluation of monoketene compounds as novel potential Parkinson's disease agents by suppressing ER stress via AKT;Bioorganic Chemistry;2023-07

5. Whether the Subacute MPTP-Treated Mouse is as Suitable as a Classic Model of Parkinsonism;NeuroMolecular Medicine;2023-03-13